Abstract | BACKGROUND: Cortical spreading depression can cause migraine attack, and up-regulate matrix metalloproteinase-9 (MMP-9) expression in animal. This study aimed to determine the impact on the structure and function of the blood-brain barrier by measuring plasma MMP-9 levels in patients at the acute and late stages of migraine attacks in order to elucidate the pathological mechanisms involved. METHODS: We recruited a case-control cohort of 38 adult migraine patients and 20 age- and gender-matched healthy control subjects. Five milliliter blood samples were collected at the acute and late stages of migraine (days 1 - 7), and also from the control subjects. Solid phase double antibody sandwich enzyme-linked immunosorbent assay was used to determine plasma MMP-9 levels. Statistical analysis was performed using the SAS version 9.1. RESULTS: Initial plasma MMP-9 levels of migraine patients were significantly higher than those of controls ((12.612 ± 0.016) µg/L vs. (6.069 ± 0.023) µg/L, respectively, P < 0.05). High MMP-9 expression was observed during days 1 - 6 of migraine attacks, with highest expression occurring on day 3 ((17.524 ± 0.035) µg/L). During attacks, MMP-9 levels were similar in migraine patients with and without aura (P > 0.05); in addition, levels were not correlated with degree of headache pain (P > 0.05). CONCLUSIONS: We hypothesize that migraine could lead to increased plasma MMP-9 levels resulting in blood-brain barrier damage. MMP-9 levels increase during days 1 - 6 of migraine attacks, peaking on day 3. Therefore, MMP-9 could be used as a biological marker to guide treatment of migraine attacks.
|
Authors | Hong-Mei Gao, Le Li, Ke-Ling Zhang, Xu-Hui Chen, Shu-Qing Tian, Zhong-Ling Zhang |
Journal | Chinese medical journal
(Chin Med J (Engl))
Vol. 123
Issue 18
Pg. 2559-61
(Sep 2010)
ISSN: 2542-5641 [Electronic] China |
PMID | 21034616
(Publication Type: Journal Article)
|
Chemical References |
- Matrix Metalloproteinase 9
|
Topics |
- Adult
- Blood-Brain Barrier
(metabolism)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Male
- Matrix Metalloproteinase 9
(blood)
- Middle Aged
- Migraine Disorders
(physiopathology)
- Young Adult
|